GlobalCapital plc Board Members

Prof Paolo Catalfamo Chairman Prof Paolo Catalfamo is the founder of Investar, based in Malta, Luxembourg, Switzerland and the US, and Professor at the Villanova School of Business in Philadelphia. He serves as Chairman of Global Capital plc, a financial conglomerate listed on the Malta Stock Exchange. He is also Chairman of Global Capital Life Insurance ltd, Chairman of Global Capital Health Insurance ltd and Chairman of Global Capital Financial Management ltd, all regulated by the Malta Financial Services Authority. He’s a Board Member of Centtrip Ltd, a London-based fintech company regulated by the UK Financial Conduct Authority. Previously, he served as Deputy Chairman and CEO for Italy and Southern Europe of Franklin Templeton, the world third largest independent asset management group.
Mr Joseph Schembri Senior Independent Director Mr Schembri is a consultant with Baker Tilly Sant. Mr Schembri is a certified public accountant and auditor. He was an audit partner of Joseph Tabone & Co and Senior Partner of KPMG Malta, as well as a board member of the KPMG regional practice specialising in Financial Services. Mr Schembri has also acted for a three-year period as director of EneMalta Corporation and as a member on the Disciplinary Committee of the Accountancy Board and the Malta Institute of Accountants. Mr Schembri was actively involved in the setting up of a KPMG member firm in Libya, acting as risk management principal as well as audit principal for foreign owned oil and gas clients operating in Libya. Mr Schembri sits on the Audit, Risk and the Remuneration and Nominations Committees of the Board of Directors of the Company.
Mr Joseph Del Raso Director Dr Del Raso is a partner in the Commercial Department of Pepper Hamilton LLP. He is experienced in assisting businesses with a variety of international and domestic transactions, and advises on government relations on the federal, state and international level. Dr Del Raso leads the firm’s Investment Management Practice Group and is co-chair of the firm’s Italian Desk and a practice leader for mutual funds of the firm’s Funds Services Practice Group. He is a past member of Pepper Hamilton’s executive committee and currently serves as a director of Freeh Group International Solutions, a Pepper Hamilton subsidiary. Dr Del Raso sits on the Audit, the Remuneration and Nominations Committees of the Board of Directors of the Company.
Mr Peter Astleford Director Mr Peter Astleford is a management consultant and independent director. He has over 25 years' experience as a leading financial services lawyer, providing advice to fund managers, banks, brokers and corporates with regard to financial services regulatory work and investment funds. Mr Astleford was a partner at Dechert LLP between 1997 and 2017, during which time he created and led the firm's financial services group in Europe, Asia and the Middle East. Prior to joining Dechert LLP, Mr. Astleford practised as a solicitor at a boutique city firm, joining as an associate in 1994 and becoming a partner in 1995. Between 1990 and 1994, he held positions at INVESCO MIM PLC, the London listed holding company to the international financial service group, first as a group legal adviser and latterly as head of corporate services. Mr Astleford qualified as a solicitor in 1986 with Linklaters, where he practised in London and Brussels. Mr Astleford was a director of Dechert Secretarial Limited until October 2017 and Dechert (Singapore) Pte until December 2017. He is today a director of Episode Inc. and M&G General Partner Inc.
Dr Carl Jude Schramm Director Dr Schramm is University Professor at Syracuse University and former president of the Ewing Marion Kauffman Foundation. Kauffman is the world’s largest philanthropy dedicated to promoting entrepreneurship. Schramm is recognized internationally as a leading authority on innovation, entrepreneurship, and economic growth. The Economist has referred to Schramm as the “evangelist of entrepreneurship.” Schramm, in partnership with former British Prime Minister Gordon Brown, created Global Entrepreneurship Week, now observed in 170 countries. While a professor at Johns Hopkins, Dr Schramm founded the nation’s first research centre on healthcare finance. He has founded or co-founded five companies, including HCIA and Greenspring Advisors. Dr Schramm also has served in major corporate roles including EVP of Fortis (now Assurant) and CEO of Fortis Healthcare. He has advised major corporations including Apple, Ford, Johnson & Johnson, Hospital Corporation of America and numerous insurance companies and venture capital funds. From 2009 to 2012 he served as a member of the Singapore Prime Minister’s Research, Innovation, and Enterprise Council. He was President of the Health Insurance Association of America between 1987 and 2012. He chaired the U.S. Department of Commerce’s Advisory Committee on Measuring Innovation in the 21st Century Economy and was a member of the President’s National Advisory Council on Innovation and Entrepreneurship. Dr Schramm is a trustee of the Templeton World Charity Foundation and a member of the National Academies of Sciences’ Government-University-Industry Research Roundtable. Schramm currently serves as chair of the Scientific Committee of the Apple Global Developer Academy at the University of Naples and as a member of the Scientific Advisory Board of Mars, Inc. He was the inaugural Arthur & Carlyse Ciocca Visiting Professor of Innovation and Entrepreneurship at UC Davis in the academic years 2013 and 2014, and has served as a visiting scientist at MIT. Professor Schramm holds a Ph.D. in economics from Wisconsin, where he was a Ford Foundation Fellow and a New York State Regents Graduate Fellow, and a law degree at Georgetown. He held two consecutive Career Scientist Awards from NIH and was a Robert Wood Johnson Foundation Health Policy Fellow at the National Academy of Medicine. He holds five honorary degrees and the University of Rochester’s George Eastman Medal. He is a member of the Council on Foreign Relations and a Fellow of the Royal Society of Arts. Dr Schramm has served as a director of Helios and Matheson Analytics Inc (NASDAQ: HMNY).
Mr Greg McGowan Director Mr Gregory Eugene McGowan, also known as Greg, J.D., serves as an Executive Vice President and the General Counsel at Templeton International Inc. Mr. McGowan serves as also an Executive Vice President at Templeton Investment Counsel, LLC. He serves as the Senior Vice President, the Executive Vice President of International Development and the Chief International General Counsel at Templeton Worldwide, Inc. Mr. McGowan serves as an Executive Vice President and Director of Templeton Global Advisors Limited. He joined Templeton Global Advisors Limited in 1986. He served as President at Templeton Global Govt., Templeton Emerging Markets Income Fund and Templeton Global Income Fund since 1996. Mr McGowan served as a Venture Advisor at Zero Stage Capital. Prior to this, he served as a Senior Attorney for the United States Securities and Exchange Commission. Mr McGowan serves as a Director at Templeton Asset Management Limited. He has been non-executive Director at Templeton Global Growth Fund Ltd. since January 1999. He serves as a Director at Templeton International Inc., Templeton Worldwide, Inc., and Franklin Templeton Investments Australia Limited. He has been Director at GlobalCapital plc since July 13, 2017. Mr McGowan serves as Director of Franklin Templeton Investments Japan Limited, Templeton Investment Counsel LLC, Franklin Templeton International Services S.A., Franklin Templeton Investments Asia Limited and Franklin Templeton Holding Limited. He is a J. D. from Georgetown University Law Centre. Mr McGowan holds an M.A. degree from the University of Paris and a B.A. degree in Economics and International Affairs from the University of Pennsylvania.
Mr Luca Galli Director Mr Galli, a business consultant and qualified electrical engineer, is the Chairman and shareholder of Eniac TLC Srl, a company in active in the energy sector. He is also director general of Fondazione Minoprio, Chairman of the Board of Directors of Serenissima Sgr Spa, Chairman of the foundation Fondazione Comunitaria del Varesotto, and a director of A4 Holding Spa, Infracom Spa, 2l Rete Gas Spa. He has served in the past on the board of Finlombarda SPA, Fondazione Cariplo, Finlombarda gestioni Sgr S.P.A, M.A.C. S.R.L, Banca IMI., Mediocredito Italiano S.P.A, Cassa di Risparmio di Foligno S.P.A., San Paolo IMI Fondi chiusi SGR S.P.A., Cassa di risparmio di Viterbo S.P.A., Credito Industriale Sardo S.P.A., Instituto Scientifico Breda S.P.A., Magazzini Generali S.P.A., Fondazione Giordano dell’ Amore, V.A.P.R.A. S.P.A., F.G.D.A. Srl and a member of the scientific commission of Fondazione Cariplo for scientific research. Mr. Galli sits on the Audit Committee of the Board of Directors of the Company.
Ms Cinzia Catalfamo-Akbaraly Director Cinzia Catalfamo studied Economics at the Bocconi University in Milan, focusing in particular on developing countries. After moving to Madagascar in 1993, she set up the Fihavanana Association to help orphaned and more disadvantaged children, followed in 2008 by the Akbaraly Foundation, a humanitarian organization that works to improve living conditions in Madagascar, focusing in particular on the health of women and children. In 2010, she launched 4aWoman, the first integrated healthcare project focusing on cancer prevention in sub-Saharan Africa, in partnership with the local Ministry of Public Health and the World Health Organization. Since 2017 she is Manager of Global Academic Network and Interagency Partnerships at FIFA. Last year, she became a Fellow at the Bocconi University, where she has actively contributed to the creation of the Africa Lab within the SDA School of Management, an innovative think tank and research lab aiming to contribute to the development of entrepreneurial opportunities in Africa. In the same year, she became an Advisor on GlobalCapital’s Board.
Dr Clinton V Calleja Company Secretary Dr Calleja is a practicing lawyer, specialising in the fields of corporate and commercial law. He is a partner of the law firm Guido de Marco & Associates – Advocates. Dr Calleja was appointed company secretary of GlobalCapital plc and its regulated and operating subsidiaries in 2008.

GlobalCapital plc Principal Companies

Board Members - Global Capital Life Insurance Ltd Prof Paolo Catalfamo – Chairman Ms Cristina Casingena - Managing Mr Joseph Schembri Mr Mario Galea Mr Nick Taylor
Board Members - GlobalCapital Health Insurance Agency Ltd Prof Paolo Catalfamo - Chairman Mr Jonathan Camilleri - Managing Mr Joseph Schembri Mr Mario Galea Ms Adriana Zarb Adami
Board Members - GlobalCapital Financial Management Ltd Prof Paolo Catalfamo – Chairman Mr Francesco Guarnieri - Managing Mr Joseph Schembri
Company Secretary for All Boards - Dr Clinton V Calleja

GlobalCapital plc Committees

Audit Committee

The Audit Committee is composed entirely of non-executive Directors and assists the Board in monitoring and reviewing the Group’s financial statements, accounting policies and internal control mechanisms in accordance with the Committee’s terms of reference.  The responsibilities of the Audit Committee also include the review and approval of related party transactions in accordance with the Listing Rules.

The Audit Committee also approves and reviews the Group’s Compliance Plan and Internal Audit Plan prior to the commencement of every financial year and monitors the implementation of these plans. 

The Group’s Internal Auditors, the Company’s External Auditors and Chief Financial Officer are invited to attend Audit Committee Meetings on a regular basis, as deemed appropriate.

The Committee comprises:

  • Mr Joseph Schembri
  • Mr Joseph Del Raso
  • Mr Peter Astleford

Nominations and Remunerations Committee

The Nominations and Remuneration Committee is responsible for making recommendations for appointment to the Board and for reviewing the constitution of the Group’s Boards, in order to ensure that appointments to Boards are conducted in a systematic, objective and consistent manner.  It is also responsible for the review of performance of the Group’s Board members and committees, the appointment of senior executives and management and the development of a succession plan for senior executives and management.

Additionally, this committee monitors, reviews and advises on the Group’s remuneration policy as well as approves the remuneration packages of senior executives and management.

The Committee comprises:

  • Mr Joseph Schembri
  • Mr Joseph Del Raso

Company Announcements